UECKER DARRIN 4
4 · PULSE BIOSCIENCES, INC. · Filed Sep 18, 2025
Insider Transaction Report
Form 4
UECKER DARRIN
DirectorChief Technology Officer
Transactions
- Sale
Common Stock
2025-09-17$16.21/sh−20,000$324,200→ 122,872 total - Exercise/Conversion
Stock Option (right to buy)
2025-09-17−61,534→ 0 totalExercise: $4.00From: 2019-09-08Exp: 2025-09-20→ Common Stock (61,534 underlying) - Exercise/Conversion
Common Stock
2025-09-16$4.00/sh+25,000$100,000→ 147,872 total - Sale
Common Stock
2025-09-16$16.28/sh−25,000$407,000→ 122,872 total - Exercise/Conversion
Common Stock
2025-09-17$4.00/sh+61,534$246,136→ 184,406 total - Exercise/Conversion
Common Stock
2025-09-17$4.00/sh+20,000$80,000→ 142,872 total - Exercise/Conversion
Common Stock
2025-09-17$4.00/sh+100,000$400,000→ 284,406 total - Exercise/Conversion
Stock Option (right to buy)
2025-09-17−20,000→ 61,534 totalExercise: $4.00From: 2019-09-08Exp: 2025-09-20→ Common Stock (20,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2025-09-16−25,000→ 81,534 totalExercise: $4.00From: 2019-09-08Exp: 2025-09-20→ Common Stock (25,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2025-09-17−100,000→ 0 totalExercise: $4.00From: 2019-09-08Exp: 2025-09-20→ Common Stock (100,000 underlying)
Footnotes (5)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025.
- [F2]The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $15.49 to $16.78 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.
- [F3]The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $16.00 to $16.44 per share.
- [F4]Options granted in connection with Reporting Person's hire became fully vested upon the four year anniversary of his Start Date, September 8, 2019, pursuant to the terms of his Employment Agreement dated September 8, 2015.
- [F5]Incentive stock options granted in connection with Reporting Person's hire became fully vested upon the four year anniversary of his Start Date, September 8, 2019, pursuant to the terms of his Employment Agreement dated September 8, 2015.